Stonepine Capital Management, LLC — 13F Holdings & Portfolio
CIK 1440771 · latest 13F-HR filed 2026-08-17
Stonepine Capital Management, LLC manages $177.3M in 13F-reported U.S. long-equity assets across 87 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are VSTM (7.22%), EOLS (6.23%), TENX (5.42%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 0 new positions, exited 10, added to 0, and trimmed 13.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 100-11
BEND, OR 97703
$177.3M
Long-equity book
87
Distinct positions
2026-06-30
Filed 2026-08-17
+0 / −10 / ↑0 / ↓13
vs 2026-06-30
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- AYTU BIOPHARMA INC-$7.7M -79.6%
- AZITRA INC-$7.1M -88.9%
- CNS PHARMACEUTICALS INC-$6.2M -96.9%
- INHIBIKASE THERAPEUTICS INC-$1.6M -66.2%
- CURIS INC-$1.4M -45.1%
Exited Positions
- SURROZEN INC$4.7M
- ADIAL PHARMACEUTICALS INC$1.6M
- IMAGENEBIO INC$539.0K
- MILESTONE PHARMACEUTICALS IN$348.6K
- VERRICA PHARMACEUTICALS INC$241.5K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | VERASTEM INC | VSTM | 92337C203 | $12.8M | 7.22% | 3,349,627 | SH |
| 2 | EVOLUS INC | EOLS | 30052C107 | $11.0M | 6.23% | 1,590,162 | SH |
| 3 | TENAX THERAPEUTICS INC | TENX | 88032L605 | $9.6M | 5.42% | 660,000 | SH |
| 4 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $8.4M | 4.75% | 120,654 | SH |
| 5 | ADMA BIOLOGICS INC Call | ADMA | 000899104 | $8.0M | 4.48% | 650,000 | SH |
| 6 | ADMA BIOLOGICS INC | ADMA | 000899104 | $6.2M | 3.49% | 740,000 | SH |
| 7 | CAMP4 THERAPEUTICS CORP | CAMP | 13463J101 | $6.1M | 3.43% | 1,389,622 | SH |
| 8 | INSMED INC Call | INSM | 457669307 | $5.6M | 3.16% | 40,000 | SH |
| 9 | ELOXX PHARMACEUTICALS INC | ELOX | 29014R301 | $5.5M | 3.11% | 397,160 | SH |
| 10 | ULTRAGENYX PHARMACEUTICAL IN Call | RARE | 90400D108 | $5.5M | 3.10% | 200,000 | SH |
| 11 | KAZIA THERAPEUTICS LTD | KZIA | 48669G303 | $4.9M | 2.74% | 345,179 | SH |
| 12 | MEDTRONIC PLC Call | MDT | G5960L103 | $4.4M | 2.47% | 50,000 | SH |
| 13 | INDIVIOR PHARMACEUTICALS INC | INDV | 45579U109 | $4.1M | 2.31% | 100,000 | SH |
| 14 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 21833P301 | $4.0M | 2.25% | 425,000 | SH |
| 15 | ABBOTT LABORATORIES Call | ABT | 002824100 | $3.8M | 2.14% | 40,000 | SH |
| 16 | SATELLOS BIOSCIENCE INC | MSLE | 80401L803 | $3.7M | 2.10% | 491,624 | SH |
| 17 | ZEVRA THERAPEUTICS INC | ZVRA | 488445206 | $3.7M | 2.09% | 258,701 | SH |
| 18 | ABEONA THERAPEUTICS INC | ABEO | 00289Y206 | $3.4M | 1.94% | 557,284 | SH |
| 19 | BOSTON SCIENTIFIC CORP Call | BSX | 101137107 | $3.2M | 1.83% | 50,000 | SH |
| 20 | EDESA BIOTECH INC | EDSA | 27966L306 | $3.2M | 1.80% | 456,439 | SH |
| 21 | EVOLUS INC Call | EOLS | 30052C107 | $3.1M | 1.78% | 420,000 | SH |
| 22 | BIOMARIN PHARMACEUTICAL INC Call | BMRN | 09061G101 | $3.1M | 1.76% | 50,000 | SH |
| 23 | CABALETTA BIO INC | CABA | 12674W109 | $2.9M | 1.61% | 917,100 | SH |
| 24 | AN2 THERAPEUTICS INC | ANTX | 037326105 | $2.7M | 1.51% | 551,692 | SH |
| 25 | XILIO THERAPEUTICS INC | XLO | 98422T209 | $2.2M | 1.22% | 225,994 | SH |
| 26 | ADICET BIO INC | ACET | 007002207 | $2.1M | 1.20% | 245,518 | SH |
| 27 | XERIS BIOPHARMA HOLDINGS INC Call | XERS | 98422E103 | $2.1M | 1.18% | 280,000 | SH |
| 28 | TELA BIO INC | TELA | 872381108 | $2.0M | 1.13% | 2,662,427 | SH |
| 29 | AYTU BIOPHARMA INC | AYTU | 054754858 | $2.0M | 1.11% | 912,921 | SH |
| 30 | CURIS INC | CRIS | 231269309 | $1.7M | 0.98% | 3,312,185 | SH |
| 31 | SPRUCE BIOSCIENCES INC | SPRB | 85209E208 | $1.6M | 0.88% | 28,795 | SH |
| 32 | HERON THERAPEUTICS INC Call | HRTX | 427746102 | $1.5M | 0.85% | 1,000,000 | SH |
| 33 | SI BONE INC Call | SIBN | 825704109 | $1.5M | 0.85% | 100,000 | SH |
| 34 | OKYO PHARMA LTD | OKYO | G6724L116 | $1.3M | 0.73% | 862,996 | SH |
| 35 | NEUMORA THERAPEUTICS INC. Call | NMRA | 640979100 | $1.2M | 0.71% | 500,000 | SH |
| 36 | PASITHEA THERAPEUTICS CORP | KTTA | 70261F202 | $1.1M | 0.64% | 2,201,468 | SH |
| 37 | SOL-GEL TECHNOLOGIES LTD | SLGL | M8694L137 | $1.1M | 0.61% | 14,469 | SH |
| 38 | PULMONX CORP | LUNG | 745848101 | $1.1M | 0.60% | 815,436 | SH |
| 39 | X4 PHARMACEUTICALS INC | XFOR | 98420X202 | $1.1M | 0.59% | 224,989 | SH |
| 40 | ARDELYX INC Call | ARDX | 039697107 | $1.1M | 0.59% | 150,000 | SH |
| 41 | DELCATH SYS INC Call | DCTH | 24661P807 | $1.0M | 0.56% | 100,000 | SH |
| 42 | IN8BIO INC | INAB | 45674E208 | $980.4K | 0.55% | 695,287 | SH |
| 43 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 61559X104 | $973.5K | 0.55% | 50,000 | SH |
| 44 | QUOIN PHARMACEUTICALS LTD | QNRX | 74907L409 | $965.5K | 0.54% | 199,486 | SH |
| 45 | MAXCYTE INC | MXCT | 57777K106 | $924.5K | 0.52% | 751,606 | SH |
| 46 | PHATHOM PHARMACEUTICALS INC | PHAT | 71722W107 | $922.4K | 0.52% | 85,010 | SH |
| 47 | AZITRA INC | AZTR | 05479L302 | $886.9K | 0.50% | 5,285,476 | SH |
| 48 | CONNECT BIOPHARMA HLDGS LTD | CNTB | G23549101 | $866.9K | 0.49% | 364,254 | SH |
| 49 | CYBIN INC | HELP | 23256X407 | $854.5K | 0.48% | 129,280 | SH |
| 50 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 90400D108 | $834.8K | 0.47% | 25,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-17 | $177.3M | 87 | 0001440771-26-000016 |
| 2026-06-30 | 2026-08-14 | $213.6M | 97 | 0001440771-26-000014 |
| 2026-03-31 | 2026-05-14 | $249.7M | 83 | 0001440771-26-000002 |
| 2025-12-31 | 2026-02-13 | $137.0M | 66 | 0000935836-26-000090 |
| 2025-09-30 | 2025-11-13 | $123.0M | 58 | 0000935836-25-000666 |